Senzime

Senzime is a company that develops monitoring systems to assess patients'​ biochemical and physiological processes before, during, and after surgery. It provides bedside solutions that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues. The company also develops TetraGraph, a digital system for monitoring patients undergoing anesthesia with neuromuscular blocking agents (NMBAs).